National Vaccination Coverage Among Adolescents Aged 13-17 Years - National Immunization Survey-Teen, United States, 2023.

IF 25.4 1区医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

MMWR. Morbidity and mortality weekly report Pub Date : 2024-08-22 DOI:10.15585/mmwr.mm7333a1

Cassandra Pingali, David Yankey, Michael Chen, Laurie D Elam-Evans, Lauri E Markowitz, Carla L DeSisto, Sarah F Schillie, Michelle Hughes, Madeleine R Valier, Shannon Stokley, James A Singleton

{"title":"National Vaccination Coverage Among Adolescents Aged 13-17 Years - National Immunization Survey-Teen, United States, 2023.","authors":"Cassandra Pingali, David Yankey, Michael Chen, Laurie D Elam-Evans, Lauri E Markowitz, Carla L DeSisto, Sarah F Schillie, Michelle Hughes, Madeleine R Valier, Shannon Stokley, James A Singleton","doi":"10.15585/mmwr.mm7333a1","DOIUrl":null,"url":null,"abstract":"<p><p>Based on safety and efficacy data, vaccinations are the best defense to protect persons and communities from serious vaccine-preventable diseases. The Advisory Committee on Immunization Practices recommends routine vaccination of adolescents aged 11-12 years with three vaccines including tetanus, diphtheria, and acellular pertussis vaccine; quadrivalent meningococcal conjugate vaccine; and human papillomavirus vaccine. CDC analyzed data from the 2023 National Immunization Survey-Teen for 16,658 adolescents aged 13-17 years (born during January 2005-December 2010) to assess vaccination coverage in 2023, recent trends in coverage by birth year, and trends in coverage by eligibility for the Vaccines for Children (VFC) program and birth year. In 2023, coverage with all routine vaccines recommended for adolescents was similar to coverage in 2022. Vaccination coverage among VFC-eligible adolescents was generally stable during the COVID-19 pandemic, except for a decrease in the percentage of VFC-eligible adolescents who were up to date with HPV vaccination by age 13 years among those born in 2010 compared with those born in 2007. Whereas coverage differences were found between VFC-eligible and non-VFC-eligible adolescents before the COVID-19 pandemic, coverage was similar among the most recent birth years in the survey. Providers should make strong recommendations for all routine vaccines and review adolescent vaccination records to verify if adolescents are up to date with all recommended vaccines.</p>","PeriodicalId":18637,"journal":{"name":"MMWR. Morbidity and mortality weekly report","volume":"73 33","pages":"708-714"},"PeriodicalIF":25.4000,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11349384/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"MMWR. Morbidity and mortality weekly report","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.15585/mmwr.mm7333a1","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}

引用次数: 0

Abstract

Based on safety and efficacy data, vaccinations are the best defense to protect persons and communities from serious vaccine-preventable diseases. The Advisory Committee on Immunization Practices recommends routine vaccination of adolescents aged 11-12 years with three vaccines including tetanus, diphtheria, and acellular pertussis vaccine; quadrivalent meningococcal conjugate vaccine; and human papillomavirus vaccine. CDC analyzed data from the 2023 National Immunization Survey-Teen for 16,658 adolescents aged 13-17 years (born during January 2005-December 2010) to assess vaccination coverage in 2023, recent trends in coverage by birth year, and trends in coverage by eligibility for the Vaccines for Children (VFC) program and birth year. In 2023, coverage with all routine vaccines recommended for adolescents was similar to coverage in 2022. Vaccination coverage among VFC-eligible adolescents was generally stable during the COVID-19 pandemic, except for a decrease in the percentage of VFC-eligible adolescents who were up to date with HPV vaccination by age 13 years among those born in 2010 compared with those born in 2007. Whereas coverage differences were found between VFC-eligible and non-VFC-eligible adolescents before the COVID-19 pandemic, coverage was similar among the most recent birth years in the survey. Providers should make strong recommendations for all routine vaccines and review adolescent vaccination records to verify if adolescents are up to date with all recommended vaccines.

查看原文本刊更多论文

2023 年美国 13-17 岁青少年疫苗接种覆盖率--全国免疫接种调查--青少年。

根据安全性和有效性数据，接种疫苗是保护个人和社区免受疫苗可预防的严重疾病侵害的最佳方法。免疫实践咨询委员会建议 11-12 岁青少年常规接种三种疫苗，包括破伤风、白喉和无细胞百日咳疫苗；四价脑膜炎球菌结合疫苗；以及人类乳头瘤病毒疫苗。美国疾病预防控制中心分析了 2023 年全国免疫接种调查中 16,658 名 13-17 岁青少年（2005 年 1 月至 2010 年 12 月期间出生）的数据，以评估 2023 年的疫苗接种覆盖率、按出生年份划分的近期覆盖率趋势以及按儿童疫苗 (VFC) 计划资格和出生年份划分的覆盖率趋势。2023 年，建议青少年接种的所有常规疫苗的覆盖率与 2022 年的覆盖率相似。在 COVID-19 大流行期间，符合 VFC 计划资格的青少年的疫苗接种覆盖率基本保持稳定，但 2010 年出生的青少年与 2007 年出生的青少年相比，符合 VFC 计划资格的青少年在 13 岁之前完成 HPV 疫苗接种的比例有所下降。在 COVID-19 大流行之前，符合 VFC 条件的青少年与不符合 VFC 条件的青少年之间存在覆盖率差异，而在调查中，最近出生年份的青少年覆盖率相似。医疗服务提供者应大力推荐所有常规疫苗，并审查青少年疫苗接种记录，以核实青少年是否接种了所有推荐的最新疫苗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

MMWR. Morbidity and mortality weekly report PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH -

CiteScore

65.40

自引率

0.90%

发文量

309

期刊介绍： The Morbidity and Mortality Weekly Report (MMWR ) series is prepared by the Centers for Disease Control and Prevention (CDC). Often called “the voice of CDC,” the MMWR series is the agency’s primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. MMWR readership predominantly consists of physicians, nurses, public health practitioners, epidemiologists and other scientists, researchers, educators, and laboratorians.